Entering text into the input field will update the search result below

Dr. Reddy's launches generic Clolar in U.S.

Nov. 14, 2017 6:55 AM ETDr. Reddy's Laboratories Limited (RDY) StockBy: Douglas W. House, SA News Editor
  • Dr. Reddy's Laboratories (NYSE:RDY) launches its generic version of Sanofi Genzyme's leukemia med Clolar (clofarabine injection) in the U.S. According to IQVIA, the market is ~$53M.
  • Mylan N.V. launched its generic version last week.

Recommended For You

More Trending News

About RDY Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
RDY--
Dr. Reddy's Laboratories Limited